# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-022183
Filing Date
2024-05-09
Accepted
2024-05-09 16:01:01
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vyne-20240331.htm iXBRL | 10-Q | 711695
2 | EX-31.1 | vyne-20240331xexx311.htm | EX-31.1 | 9603
3 | EX-31.2 | vyne-20240331xexx312.htm | EX-31.2 | 9597
4 | EX-32.1 | vyne-20240331xexx321.htm | EX-32.1 | 5242
5 | EX-32.2 | vyne-20240331xexx322.htm | EX-32.2 | 5237
| Complete submission text file | 0001628280-24-022183.txt |  | 4475218

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vyne-20240331.xsd | EX-101.SCH | 34021
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vyne-20240331_cal.xml | EX-101.CAL | 45501
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vyne-20240331_def.xml | EX-101.DEF | 150669
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vyne-20240331_lab.xml | EX-101.LAB | 471333
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vyne-20240331_pre.xml | EX-101.PRE | 318424
61 | EXTRACTED XBRL INSTANCE DOCUMENT | vyne-20240331_htm.xml | XML | 436394

Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 24930276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)